Table 2.
Regression results
| Control | LVM | LVMHt2.7 | RWT | E/A | E/e’ |
|---|---|---|---|---|---|
|
| |||||
| ref | ref | ref | ref | ref | |
| Mild NAFLD | -9.09 (-26.68, 8.50) | -2.09 (-6.69, 2.51) | 0.01 (-0.02, 0.04) | -0.08 (-0.22. 0.06) | 0.22 (-0.36, 1.08) |
| Severe NAFLD | 12.53 (-11.42, 36.47) | 6.66 (0.39, 12.92)* | 0.05 (0.02, 0.09)** | -0.39 (-0.58, -0.19)*** | -0.28 (-0.67, 0.12) |
| MetS only | 12.78 (-5.69, 31.25) | 0.99 (-3.84, 5.80) | 0.05 (0.02, 0.09)*** | -0.13 (-0.28, 0.01) | -0.16 (-0.52, 0.26) |
| NAFLD and MetS combined | 16.42 (-3.85, 36.68) | 3.98 (-1.32, 9.28) | 0.05 (0.02, 0.08)** | -0.14 (-0.30, 0.02) | -0.21 (-0.54, 0.12) |
Significance codes:
***
P < 0.001;
**
P < 0.01;
*
P < 0.05.
Abbreviations: NAFLD: Nonalcoholic fatty liver disease; MetS: Metabolic syndrome; LVM: Left ventricular mass; LVMHt2.7: Left ventricular mass after normalization for height2.7; RWT: Relative wall thickness; E/A: Ratio between peak early (E) and late (A) diastolic ventricular filling velocities; E/e’: Ratio between early mitral inflow velocity (E) and mitral annular early diastolic velocity (e’).